Page last updated: 2024-09-05

alagebrium and pimagedine

alagebrium has been researched along with pimagedine in 16 studies

Compound Research Comparison

Studies
(alagebrium)
Trials
(alagebrium)
Recent Studies (post-2010)
(alagebrium)
Studies
(pimagedine)
Trials
(pimagedine)
Recent Studies (post-2010) (pimagedine)
8310312,16218390

Protein Interaction Comparison

ProteinTaxonomyalagebrium (IC50)pimagedine (IC50)
Nitric oxide synthase, brainHomo sapiens (human)5.9
Nitric oxide synthase, inducibleHomo sapiens (human)4.2

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (75.00)29.6817
2010's4 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grill, V; Hiramatsu, S; Inoue, K; Tajirl, Y1
Kawakami, M; Kuroki, M1
Cooper, M; Forbes, J; Jerums, G; Osicka, T; Panagiotopoulos, S1
Foiles, P; Founds, H; Vasan, S1
Allen, TJ; Burns, WC; Candido, R; Cooper, ME; Deemer, EK; Forbes, JM; Jandeleit-Dahm, KA; Lassila, M; Thallas, V; Thomas, MC; Thorpe, SM; Thorpe, SR; Yee, LT1
Bach, LA; Boner, G; Cooper, ME; Forbes, JM; Haller, H; Lindschau, C; Meier, M; Rizkalla, B; Thallas-Bonke, V1
Cui, H; Li, S; Wang, LL; Zhong, W1
Imaizumi, T; Yamagishi, S1
Bivalacqua, TJ; Cellek, S; Foxwell, NA; Gur, S; Hellstrom, WJ; Kendirci, M; Usta, MF1
Chin-Dusting, JP; Cooper, ME; Coughlan, MT; Forbes, JM; Hoang, A; Murphy, AJ; O'Brien, R; Sviridov, D; Thomas, MC1
Gangula, PR; Jeyabal, PV; Kumar, R; Micci, MA; Pasricha, PJ1
Barter, PJ; Brown, BE; Davies, MJ; Nobécourt, E; Rye, KA; Yadav, S; Zeng, J1
Ferrucci, L; Nicklett, EJ; Semba, RD1
Engelen, L; Schalkwijk, CG; Stehouwer, CD1
André-Frei, V; Bechetoille, N; Berthod, F; Cadau, S; Leoty-Okombi, S; Pain, S1
Chao, TF; Chen, YJ; Kao, YH; Lee, TI; Lee, TW1

Reviews

8 review(s) available for alagebrium and pimagedine

ArticleYear
[Aminoguanidine and other AGE inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hydrazines; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines

2002
Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease.
    Archives of biochemistry and biophysics, 2003, Nov-01, Volume: 419, Issue:1

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Enzyme Inhibitors; Forecasting; Glycation End Products, Advanced; Guanidines; Humans; Protein Kinase C; Ramipril; Renin-Angiotensin System; Thiazoles

2003
Therapeutic potential of breakers of advanced glycation end product-protein crosslinks.
    Archives of biochemistry and biophysics, 2003, Nov-01, Volume: 419, Issue:1

    Topics: Aging; Animals; Clinical Trials as Topic; Cross-Linking Reagents; Diabetes Mellitus; Diastole; Drug Evaluation, Preclinical; Elasticity; Glycation End Products, Advanced; Guanidines; Humans; Hypertrophy, Left Ventricular; Molecular Structure; Myocardium; Proteins; Skin; Thiazoles

2003
[Targeted AGEes and AGEs cross-link in drug discovery: preventing and reversing arterial sclerosis in aging and diabetes].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2005, Volume: 40, Issue:1

    Topics: Aging; Animals; Arteries; Arteriosclerosis; Blood Pressure; Diabetes Mellitus; Glycation End Products, Advanced; Guanidines; Humans; Thiazoles

2005
[Progress on the drug therapy for diabetic microangiopathies: AGE inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 6

    Topics: Animals; Clinical Trials as Topic; Depression, Chemical; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Humans; Oxidative Stress; Pyridoxamine; Thiadiazoles; Thiamine; Thiazoles; Thiazolidines

2005
Does accumulation of advanced glycation end products contribute to the aging phenotype?
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2010, Volume: 65, Issue:9

    Topics: Aging; Bone and Bones; Brain; Diet; Enzyme Inhibitors; Erythrocytes; Eye; Food Analysis; Glycation End Products, Advanced; Guanidines; Humans; Inflammation; Kidney; Liver; Longevity; Muscle, Skeletal; Myocardium; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Tendons; Thiazoles

2010
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
    Diabetes, obesity & metabolism, 2013, Volume: 15, Issue:8

    Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Enzyme Inhibitors; Evidence-Based Medicine; Female; Glycation End Products, Advanced; Guanidines; Humans; Hyperglycemia; Male; Pyridoxamine; Thiamine; Thiazoles; Treatment Outcome

2013
Therapeutic potential of vitamin D in AGE/RAGE-related cardiovascular diseases.
    Cellular and molecular life sciences : CMLS, 2019, Volume: 76, Issue:20

    Topics: Actin Cytoskeleton; Animals; Calcium; Cardiotonic Agents; Diabetic Cardiomyopathies; Gene Expression Regulation; Glycation End Products, Advanced; Guanidines; Humans; Myocardial Reperfusion Injury; Myocarditis; Oxidative Stress; Receptor for Advanced Glycation End Products; Signal Transduction; Thiazoles; Vascular Stiffness; Vitamin D

2019

Other Studies

8 other study(ies) available for alagebrium and pimagedine

ArticleYear
Improvement by aminoguanidine of insulin secretion from pancreatic islets grafted to syngeneic diabetic rats.
    Biochemical pharmacology, 2000, Jul-15, Volume: 60, Issue:2

    Topics: Animals; B-Lymphocytes; Diabetes Mellitus, Experimental; Guanidines; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Proinsulin; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger; Thiazoles; Transplantation, Isogeneic

2000
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.
    Diabetes, 2004, Volume: 53, Issue:7

    Topics: Actins; Animals; Aorta; Arteriosclerosis; Collagen; Cytokines; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth; Oxidation-Reduction; Skin; Thiazoles

2004
Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.
    Diabetes, 2004, Volume: 53, Issue:11

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix Proteins; Glycation End Products, Advanced; Guanidines; Kidney Cortex; Male; Protein Kinase C; Protein Kinase C-alpha; Protein Transport; Rats; Rats, Sprague-Dawley; Thiazoles

2004
The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment.
    The journal of sexual medicine, 2006, Volume: 3, Issue:2

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dose-Response Relationship, Drug; Glycation End Products, Advanced; Guanidines; Immunohistochemistry; Impotence, Vasculogenic; Male; Rats; Rats, Sprague-Dawley; Streptozocin; Thiazoles

2006
Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.
    Diabetologia, 2007, Volume: 50, Issue:8

    Topics: Apolipoprotein A-I; Atherosclerosis; ATP-Binding Cassette Transporters; Biological Transport; CD11b Antigen; Cell Line; Cells, Cultured; Cholesterol; Electrophoresis, Polyacrylamide Gel; Glycation End Products, Advanced; Glycosylation; Guanidines; HeLa Cells; Humans; Lipid Metabolism; Lipoproteins, HDL; Phospholipids; Ribose; Thiazoles; Transfection

2007
Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
    Neurogastroenterology and motility, 2008, Volume: 20, Issue:3

    Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes Mellitus, Experimental; Duodenum; Enteric Nervous System; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Guanidines; Immunohistochemistry; Male; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Thiazoles

2008
Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.
    Diabetologia, 2008, Volume: 51, Issue:6

    Topics: Apolipoprotein A-I; Arginine; Cross-Linking Reagents; Glycosylation; Guanidines; Humans; Lipoproteins, HDL; Lysine; Metformin; Phosphatidylcholine-Sterol O-Acyltransferase; Pyridoxamine; Pyruvaldehyde; Thiazoles; Tryptophan

2008
In vitro glycation of an endothelialized and innervated tissue-engineered skin to screen anti-AGE molecules.
    Biomaterials, 2015, Volume: 51

    Topics: Animals; Capillaries; Cattle; Cell Differentiation; Cells, Cultured; Collagen; Cytoskeleton; Dermis; Endothelial Cells; Fibroblasts; Filaggrin Proteins; Glycation End Products, Advanced; Glycosylation; Glyoxal; Guanidines; Humans; Keratinocytes; Lysine; Mice; Neurons; Protective Agents; Skin; Thiazoles; Tissue Engineering

2015